Cathay Biotech's earnings have been declining at an average annual rate of -2.2%, while the Chemicals industry saw earnings declining at 5.6% annually. Revenues have been growing at an average rate of 10.9% per year. Cathay Biotech's return on equity is 2.7%, and it has net margins of 17.4%.
Key information
-2.22%
Earnings growth rate
-5.21%
EPS growth rate
Chemicals Industry Growth
12.10%
Revenue growth rate
10.89%
Return on equity
2.65%
Net Margin
17.37%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Cathay Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
XSSC:688065 Revenue, expenses and earnings (CNY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
3,394
589
254
234
31 Dec 25
3,295
561
246
238
30 Sep 25
3,288
594
242
243
30 Jun 25
3,184
550
236
256
31 Mar 25
3,049
521
228
249
31 Dec 24
2,958
489
225
233
30 Sep 24
2,764
398
238
232
30 Jun 24
2,528
372
227
203
31 Mar 24
2,293
414
198
184
31 Dec 23
2,114
367
215
189
30 Sep 23
2,169
381
235
179
30 Jun 23
2,183
459
256
187
31 Mar 23
2,285
436
270
199
31 Dec 22
2,441
553
239
188
30 Sep 22
2,447
605
207
184
30 Jun 22
2,517
619
188
164
31 Mar 22
2,538
628
182
145
31 Dec 21
2,363
595
181
134
30 Sep 21
2,099
612
143
118
30 Jun 21
1,839
564
147
99
31 Mar 21
1,579
481
144
97
31 Dec 20
1,497
458
146
84
30 Sep 20
1,482
428
181
70
30 Jun 20
1,601
432
203
41
31 Mar 20
1,722
475
258
105
31 Dec 19
1,916
479
212
90
31 Dec 18
1,757
466
185
86
31 Dec 17
1,363
333
131
65
31 Dec 16
929
145
105
38
Quality Earnings: 688065 has high quality earnings.
Growing Profit Margin: 688065's current net profit margins (17.4%) are higher than last year (17.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688065's earnings have declined by 2.2% per year over the past 5 years.
Accelerating Growth: 688065's earnings growth over the past year (13.2%) exceeds its 5-year average (-2.2% per year).
Earnings vs Industry: 688065 earnings growth over the past year (13.2%) exceeded the Chemicals industry 3.7%.
Return on Equity
High ROE: 688065's Return on Equity (2.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/09 11:20
End of Day Share Price
2026/06/09 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cathay Biotech Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.